USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	061615/0332			Pages:	7
		Recorded:	11/01/2022
Attorney Dkt #:	ABX-000
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 13

Patent #:	NONE	Issue Dt:		Application #:	16103764	Filing Dt:	08/14/2018
Publication #:	US20190071502	Pub Dt:	03/07/2019
Title:	METHODS AND COMPOSITIONS FOR TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN IN CANCER

Patent #:	NONE	Issue Dt:		Application #:	16877335	Filing Dt:	05/18/2020
Publication #:	US20200291127	Pub Dt:	09/17/2020
Title:	ANTIBODIES AND METHODS OF USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16877346	Filing Dt:	05/18/2020
Publication #:	US20200291128	Pub Dt:	09/17/2020
Title:	ANTIBODIES AND METHODS OF USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16877352	Filing Dt:	05/18/2020
Publication #:	US20200325244	Pub Dt:	10/15/2020
Title:	ANTIBODIES AND METHODS OF USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16877368	Filing Dt:	05/18/2020
Publication #:	US20200291116	Pub Dt:	09/17/2020
Title:	ANTIBODIES AND METHODS OF USE THEREOF

Patent #:	10981996	Issue Dt:	04/20/2021	Application #:	16926306	Filing Dt:	07/10/2020
Title:	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

Patent #:	10981997	Issue Dt:	04/20/2021	Application #:	16926355	Filing Dt:	07/10/2020
Title:	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	16975364	Filing Dt:	08/24/2020
Publication #:	US20200399377	Pub Dt:	12/24/2020			PCT #:	US2019019295
Title:	COMBINATION CANCER THERAPY WITH ANTI-CANCER AGENTS AND ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN

Patent #:	11359023	Issue Dt:	06/14/2022	Application #:	17199205	Filing Dt:	03/11/2021
Publication #:	US20210371532	Pub Dt:	12/02/2021
Title:	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

Patent #:	11976120	Issue Dt:	05/07/2024	Application #:	17199258	Filing Dt:	03/11/2021
Publication #:	US20220033504	Pub Dt:	02/03/2022
Title:	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	17247767	Filing Dt:	12/22/2020
Publication #:	US20210147572	Pub Dt:	05/20/2021
Title:	ANTIBODIES AND METHODS OF USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17250443	Filing Dt:	01/21/2021
Publication #:	US20210253713	Pub Dt:	08/19/2021			PCT #:	US2019043108
Title:	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	17663393	Filing Dt:	05/13/2022
Publication #:	US20220332831	Pub Dt:	10/20/2022
Title:	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

Assignor

Exec Dt:

08/25/2022

Assignee

BINGER STRASSE 173

INGELHEIM AM RHEIN, GERMANY 55216

Correspondence name and address
	GOODWIN PROCTER LLP
	THREE EMBARCADERO CENTER
	SAN FRANCISCO, CA 94111

Search Results as of: 06/03/2024 02:27 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6